Genomic structure and complete sequence of the human FGFR4 gene

被引:0
|
作者
Markus Kostrzewa
Ulrich Müller
机构
[1] Justus-Liebig-Universität Giessen,Institut für Humangenetik
来源
Mammalian Genome | 1998年 / 9卷
关键词
Craniosynostosis; Short Tandem Repeat Polymorphism; Fibroblast Growth Factor Receptor Family; Fibroblast Growth Factor Recep; Conserve Amino Acid Exchange;
D O I
暂无
中图分类号
学科分类号
摘要
We report the genomic structure and entire sequence of the fibroblast growth factor receptor 4 (FGFR4) gene. The gene spans approximately 11.3 kb. It is composed of 18 exons ranging in size from 71 bp to 600 bp. Exon-intron boundaries follow the GT/AG rule. Exon 1 is untranslated and preceded by structural elements characteristic of a TATA-free promoter. Although there are promoter motifs in intron 4 as well, there is currently no evidence of alternative transcription of FGFR4. Comparison of exon-intron boundaries of FGFR4 with those of FGFR1 and 3 reveals a remarkable degree of homology. With the exception of four, exon boundaries are at identical positions in all three receptor genes. Short tandem repeat polymorphisms (STRPs) were identified in introns 2 and 16 of FGFR4. The STRPs together with the sequence information will facilitate the rapid analysis of FGFR4 in those human disorders in which this gene can be considered a candidate.
引用
收藏
页码:131 / 135
页数:4
相关论文
共 50 条
  • [21] A Polymorphism in the FGFR4 Gene Is Associated With Risk of Neuroblastoma and Altered Receptor Degradation
    Whittle, Sarah B.
    Reyes, Sahily
    Du, Melissa
    Gireud, Monica
    Zhang, Linna
    Woodfield, Sarah E.
    Ittmann, Michael
    Scheurer, Michael E.
    Bean, Andrew J.
    Zage, Peter E.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2016, 38 (02) : 131 - 138
  • [22] Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma
    Tsay, Ming-Dow
    Hsieh, Ming-Ju
    Lee, Chia-Yi
    Wang, Shian-Shiang
    Chen, Chuan-Shu
    Hung, Sheng-Chun
    Lin, Chia-Yen
    Yang, Shun-Fa
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [23] The Role FGFR4 in Pancreatic Endocrine Tumors
    Serra, S.
    Ezzat, S.
    Chetty, R.
    Asa, S. L.
    LABORATORY INVESTIGATION, 2009, 89 : 120A - 120A
  • [24] COMPLETE SEQUENCE AND STRUCTURE OF THE GENE FOR HUMAN ADENOSINE-DEAMINASE
    WIGINTON, DA
    KAPLAN, DJ
    STATES, JC
    AKESON, AL
    PERME, CM
    BILYK, IJ
    VAUGHN, AJ
    LATTIER, DL
    HUTTON, JJ
    BIOCHEMISTRY, 1986, 25 (25) : 8234 - 8244
  • [25] FIRST SELECTIVE SMALL MOLECULE INHIBITOR OF FGFR4 FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS WITH AN ACTIVATED FGFR4 SIGNALING PATHWAY
    Hoeflich, K.
    Hagel, M.
    Miduturu, C.
    Sheets, M.
    Rubin, N.
    Weng, W.
    Stransky, N.
    Bifulco, N.
    Kim, J.
    Hodous, B.
    Brooijmans, N.
    Shutes, A.
    Winter, C.
    Lengauer, C.
    Kohl, N.
    Guzi, T.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S215 - S216
  • [26] 靶向FGFR4的miRNA筛选
    高赢政
    蔡琳
    黄佳伟
    邱梦媛
    黄通周
    数理医药学杂志, 2017, 30 (06) : 791 - 794
  • [27] FGFR3 and FGFR4 mutational analyses in thyroid carcinoma
    Serra, S.
    Cheng, S.
    Ezzat, S.
    Asa, S. L.
    LABORATORY INVESTIGATION, 2008, 88 : 110A - 111A
  • [28] FGFR3 and FGFR4 mutational analyses in thyroid carcinoma
    Serra, S.
    Cheng, S.
    Ezzat, S.
    Asa, S. L.
    MODERN PATHOLOGY, 2008, 21 : 110A - 111A
  • [29] Exploring the involvement of FGFR4 in hepatocellular carcinoma
    Ho, Han Kiat
    Pok, Sharon
    Ruhe, Jens E.
    Hart, Stefan
    Streit, Sylvia S.
    Loo, Hooi Linn
    Foo, Priscilla
    Do Aung, Myat
    Ullrich, Axel
    Lim, Seng Gee
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3549S - 3550S
  • [30] Targeting FGFR4 in colorectal cancer cells
    Heinzle, Christine
    Erdem, Zeynep
    Sonvilla, Gudrun
    Staettner, Stefan
    Karner, Josef
    Klimpfinger, Martin
    Grasl-Kraupp, Bettina
    Holzmann, Klaus
    Grusch, Michael
    Berger, Walter
    Marian, Brigitte
    CANCER RESEARCH, 2012, 72